CorMedix Inc (CRMD)

[Lazerking40]

Taking over the phase 3 trial and cleaning up the CRO's problems didn't help. I don't disagree with what you said but I do anticipate (used lightly) that the burn should start to slow with the phase 3 wrap up. Future burn will depend on how they proceed - partner, take it on themselves, etc. Working through an NDA isn't cheap and while I do think approval for hemo is likely, will the FDA require an additional phase 3 for oncology or possibly an approval with a concurrent phase 4 for other indications? Plus they still have their medical devices to work through (meshes and sutures). The approval pathway for these should also be more clear once FDA makes its decision. I guess what I am getting to is it's hard to determine future burn until we get some answers, but the 5+M in NOLS they sold, the 7.5M deal with Elliot, and a few ATM sells sets them up for at least into Q2 I would assume. All just my opinions! Good luck to you and everyone else!